Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Börgel

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
British Journal of Pharmacology|April 1, 1997
Differential effects of diadenosine phosphates on purinoceptors in the rat isolated perfused kidneyM van der Giet, M Khattab, J Börgel, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 12, 2010
Influence of glycaemic control on platelet bound CD40-CD40L system, P-selectin and soluble CD40 ligand in Type 2 diabetesH Neubauer, P Setiadi, B Günesdogan, et al.
The European Respiratory Journal|January 3, 2006
Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levelsJ Börgel, B M Sanner, A Bittlinsky, et al.
The European Respiratory Journal|March 16, 2007
Sleep apnoea in heart failureR Schulz, A Blau, J Börgel, et al.
Der Internist|August 25, 2017
[Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017]M Koziolek, J Beige, M Wallbach, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
British Journal of Pharmacology|April 1, 1997
Differential effects of diadenosine phosphates on purinoceptors in the rat isolated perfused kidneyM van der Giet, M Khattab, J Börgel, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 12, 2010
Influence of glycaemic control on platelet bound CD40-CD40L system, P-selectin and soluble CD40 ligand in Type 2 diabetesH Neubauer, P Setiadi, B Günesdogan, et al.
The European Respiratory Journal|January 3, 2006
Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levelsJ Börgel, B M Sanner, A Bittlinsky, et al.
The European Respiratory Journal|March 16, 2007
Sleep apnoea in heart failureR Schulz, A Blau, J Börgel, et al.
Der Internist|August 25, 2017
[Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017]M Koziolek, J Beige, M Wallbach, et al.
Pageof 1